TMCnet News
US Clinical Chemistry and Immunodiagnostic Market 2017-2021 - Exciting Opportunities for Instrument and Reagent Companies - Research and MarketsThe "US Clinical Chemistry and Immunodiagnostic Market Supplier Shares and Segment Forecasts 2017-2021: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers" report has been added to ResearchAndMarkets.com's offering. This new report is a strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the next five years. The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers' sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketig opportunities emerging during the next five years. Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Tests Analyzed in the Report:
Market Segmentation Analysis Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers. Test volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays, by market segment:
Companies Mentioned:
Key Topics Covered: I. Introduction II. Worldwide Market Overview III. Major Product Development Opportunities IV. Design Criteria for Decentralized Testing Products V. Alternative Market Penetration Strategies VI. Potential Market Entry Barriers and Risks VII. Worldwide Market and Technology Overview VIII. U.S.A. Clinical Chemistry and Immunodiagnostics Market IX. Competitive Assessments For more information about this report visit https://www.researchandmarkets.com/research/2s27k5/us_clinical?w=4 View source version on businesswire.com: http://www.businesswire.com/news/home/20180115005278/en/ |
